These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8788518)

  • 21. Evidence that G(z)-proteins couple to hypothalamic 5-HT(1A) receptors in vivo.
    Serres F; Li Q; Garcia F; Raap DK; Battaglia G; Muma NA; Van de Kar LD
    J Neurosci; 2000 May; 20(9):3095-103. PubMed ID: 10777773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
    Bagdy G; Kalogeras KT
    Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothalamic-pituitary-adrenal responses to 5-HT1A and 5-HT2A/C agonists are differentially altered in female and male rats prenatally exposed to ethanol.
    Hofmann CE; Ellis L; Yu WK; Weinberg J
    Alcohol Clin Exp Res; 2007 Feb; 31(2):345-55. PubMed ID: 17250628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular responses produced by microinjection of serotonin-receptor agonists into the paraventricular nucleus in conscious rats.
    Bell AA; Butz BL; Alper RH
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):175-80. PubMed ID: 10028923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
    Van de Kar LD; Raap DK; Battaglia G; Muma NA; Garcia F; DonCarlos LL
    Neuropharmacology; 2002 Jul; 43(1):45-54. PubMed ID: 12213258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subchronic treatment with anxiolytic doses of the 5-HT1A receptor agonist ipsapirone does not affect 5-HT2 receptor sensitivity in the rat.
    Baudrie V; De Vry J; Broqua P; Schmidt B; Chaouloff F; Glaser T
    Eur J Pharmacol; 1993 Feb; 231(3):395-406. PubMed ID: 8095465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine treatment of prepubescent rats produces a selective functional reduction in the 5-HT2A receptor-mediated stimulation of oxytocin.
    Landry M; Frasier M; Chen Z; Van De Kar LD; Zhang Y; Garcia F; Battaglia G
    Synapse; 2005 Nov; 58(2):102-9. PubMed ID: 16088947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of 5-HT(2A/2C) receptors within specific hypothalamic nuclei differentially antagonizes NPY-induced feeding.
    Currie PJ; Coscina DV
    Neuroreport; 1997 Dec; 8(17):3759-62. PubMed ID: 9427365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of 5-HT
    Bromek E; Rysz M; Haduch A; Wójcikowski J; Daniel WA
    Drug Metab Dispos; 2018 Jun; 46(6):786-793. PubMed ID: 29555828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists.
    Mazzola-Pomietto P; Aulakh CS; Tolliver T; Murphy DL
    Psychopharmacology (Berl); 1997 Mar; 130(2):144-51. PubMed ID: 9106912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of CRH in the effects of 5-HT-receptor agonists on food intake and metabolic rate.
    Bovetto S; Rouillard C; Richard D
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1231-8. PubMed ID: 8945958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus.
    Damjanoska KJ; Van de Kar LD; Kindel GH; Zhang Y; D'Souza DN; Garcia F; Battaglia G; Muma NA
    J Pharmacol Exp Ther; 2003 Aug; 306(2):563-71. PubMed ID: 12721328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic paraventricular 5-hydroxytryptamine: receptor-specific inhibition of NPY-stimulated eating and energy metabolism.
    Currie PJ; Coiro CD; Niyomchai T; Lira A; Farahmand F
    Pharmacol Biochem Behav; 2002 Apr; 71(4):709-16. PubMed ID: 11888562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine responses to the serotonin2 agonist DOI are differentially modified by three 5-HT1A agonists.
    Li Q; Rittenhouse PA; Levy AD; Alvarez Sanz MC; Van de Kar LD
    Neuropharmacology; 1992 Oct; 31(10):983-9. PubMed ID: 1359439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic treatment with an anxiolytic dose of the 5-HT1A agonist ipsapirone does not alter ipsapirone acute neuroendocrine effects.
    Schmidt BH; Chaouloff F
    Psychoneuroendocrinology; 1993; 18(7):457-66. PubMed ID: 7903466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat.
    Pan L; Gilbert F
    Neuroendocrinology; 1992 Dec; 56(6):797-802. PubMed ID: 1369587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained treatment with a 5-HT(2A) receptor agonist causes functional desensitization and reductions in agonist-labeled 5-HT(2A) receptors despite increases in receptor protein levels in rats.
    Shi J; Landry M; Carrasco GA; Battaglia G; Muma NA
    Neuropharmacology; 2008 Oct; 55(5):687-92. PubMed ID: 18588902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome.
    Osei-Owusu P; James A; Crane J; Scrogin KE
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1324-30. PubMed ID: 15743927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.